{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:09Z","timestamp":1786119189477,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1097\/ijg.0b013e318170a747","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T18:29:24Z","timestamp":1236277764000},"page":"140-143","source":"Crossref","is-referenced-by-count":33,"title":["Intracameral Bevacizumab (Avastin) for Neovascular Glaucoma"],"prefix":"10.1097","volume":"18","author":[{"given":"Susana","family":"Duch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Buchacra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Milla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Tellez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210208","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","article-title":"Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy","volume":"118","author":"Adamis","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"R2-9-20210208","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2006.02.045","article-title":"Intracameral bevacizumab for iris rubeosis","volume":"142","author":"Grisanti","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R3-9-20210208","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ajo.2006.06.066","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma","volume":"142","author":"Iliev","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R4-9-20210208","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ophtha.2005.10.052","article-title":"Ranibizumab for treatment of neovascular age-related macular degeneration. A phase I\/II multicenter, controlled, multidose study","volume":"113","author":"Heier","year":"2006","journal-title":"Ophthalmology"},{"key":"R5-9-20210208","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajo.2006.02.015","article-title":"Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy","volume":"142","author":"Oshima","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R6-9-20210208","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/112067210701700220","article-title":"Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion","volume":"17","author":"Vatavuk","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"R7-9-20210208","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/IJG.0b013e3180457c47","article-title":"Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma","volume":"16","author":"Yazdani","year":"2007","journal-title":"J Glaucoma"},{"key":"R8-9-20210208","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"R9-9-20210208","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00347-007-1569-y","article-title":"Bevacizumab is not toxic to human anterior- and posterior-segment cultured cells","volume":"104","author":"Kernt","year":"2007","journal-title":"Ophthalmologe"}],"container-title":["Journal of Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00061198-200902000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:46:52Z","timestamp":1786038412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00061198-200902000-00009"}},"subtitle":["A Pilot Study in 6 Patients"],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ijg.0b013e318170a747","relation":{},"ISSN":["1057-0829"],"issn-type":[{"value":"1057-0829","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}